Clinical study of autologous stromal vascular fraction gel transplantation combine with liposuction for the treatment of secondary lymphedema in limbs

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038809

Enrollment

Unknown

Registered

2020-10-03

Start date

2020-10-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Interventions

Intervention group:autologous stromal vascular fraction gel transplantation combine with liposuction

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Secondary lymphedema that meets the diagnostic criteria; 2. Patients aged 18-75 years; 3. No tumor recurrence or metastasis; 4. Voluntary subjects, signed informed consent, and patients with good compliance.

Exclusion criteria

Exclusion criteria: 1. Severe lesions of vital organs that cannot tolerate the operation; 2. Patients with hematopoietic or immune system diseases; 3. Patients with allergic constitution, scar constitution or abnormal constitution; 4. Patients with severe mental disorders and severe cognitive dysfunction shall not be operated; 5. Patients with infected lesions in the operative area; 6. Recurrence and metastasis of malignant tumor during treatment; 7. Patients whose family members do not agree with the operation.

Design outcomes

Primary

Measure	Time frame
Limb circumference measurement;Water displacement method;Lymphedema function score and Quality of Life questionnaire;	—

Contacts

Public ContactChengliang Deng

The Affiliated Hospital Of Zunyi Medical University

260851047@qq.com+86 15085115296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026